课题基金 / 基金详情

Adaptation of Hepatitis C to Host HLA-Restricted Immune Responses in Australian Populations

Adaptation of Hepatitis C to Host HLA-Restricted Immune Responses in Australian Populations
丙型肝炎在澳大利亚人群中适应 HLA 限制性免疫反应
批准号:
nhmrc : 334603
负责人:
Dr Silvana Gaudieri
金额:
$32.06万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

Dr Silvana Gaudieri的其他基金

相似基金

相关文献

中文摘要
翻译
超过200,000名澳大利亚人感染丙型肝炎病毒(HCV),每年诊断出约11,000例新感染。大约25%的HCV感染者将清除病毒,而慢性感染者中有10 - 20%将在未来20-40年内发展为肝硬化。宿主遗传因素和病毒变异的差异将在很大程度上解释观察到的HCV感染临床结局和病程的异质性。支持这项研究的基本理论是,HCV和HIV等病毒的进化受到个体HLA类型(hots)的影响,与病毒突变(摆脱有害突变)的能力相结合,以避免宿主的免疫挑战(类似于耐药性),即使以损害病毒适应性或复制的较小代价。我们已经证明,这取决于病毒遇到的免疫环境,与宿主中存在的HLA等位基因有关,因此逃逸是特定的。在传播到缺乏相同HLA类型的新宿主后,病毒消除了以前可能损害病毒适应性的有利突变。目前的研究将对来自澳大利亚多个中心的约500名HCV患者进行HCV测序和HLA分型,以确定病毒和宿主遗传因素之间的相互作用。一个定制的软件程序,Epipop,已被设计用于对生成的数据进行复杂的统计分析,并已成功应用于艾滋病毒疫苗的设计。这项研究的结果可以帮助解释为什么一些感染者可以自发清除感染,而其他人则会继续严重的肝脏疾病,并允许临床医生预测个人的感染过程并相应地计划他们的管理。此外,这些结果可能有助于寻找最佳的治疗和疫苗接种策略。
英文摘要
Over 200,000 Australians are infected with the Hepatitis C Virus (HCV) and about 11,000 new infections are diagnosed each year. Around 25% of people infected with HCV will clear the virus while for individuals with chronic infection 10 to 20% will develop cirrhosis of the liver within the next 20-40 years. Differences in host genetic factors and viral variants will, in large part, explain the observed heterogeneity in the clinical outcome and course of HCV infection. The basic theory underpinning this research is that the evolution of viruses such as HCV and HIV are influenced by the HLA type of the individual (hots), in combination with the ability of the virus to mutate (rid itself of deleterious mutations) to avoid the host's immune challenge (analogous to drug resistance) even at the lesser cost of impairing viral fitness or replication. We have shown that this is dependent on the immune environment that the virus encounters in relation to which HLA alleles are present in the host, therefore the escape is context specific. After transmission to a new host who lacks the same HLA type, the virus eliminates the previously advantageous mutations which could potentially impair viral fitness. The current study will carry out HCV sequencing and HLA typing on approximately 500 people with HCV from multiple Centres in Australia in order to characterise the interaction between the viral and host genetic factors. A customised software programme, Epipop, has been designed to perform sophisticated statistical analyses on the generated data, and has been successfully applied to HIV vaccine design. The results of this study could help explain why some infected individuals can spontaneously clear their infection while others go on to severe liver disease and allow clinicians to anticipate the course of infection in individuals and plan their management accordingly. Furthermore, the results may facilitate the search for optimal therapeutic and vaccination strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterisation of the major Histocompatability Complex (MHC) and paralogous regions within the genome:
  • 批准号:
    nhmrc : 7108
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $9.38万
  • 财政年份:
    2000
  • 负责人:
    Dr Silvana Gaudieri
  • 依托单位:
国内基金
海外基金
新生期接种乙肝疫苗(hepatitis B vaccine,HBV)影响小鼠情绪相关行为及其机制研究
  • 批准号:
    31600836
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    杨俊华
  • 依托单位: